Tranilast ameliorates cyclophosphamide-induced lung injury and nephrotoxicity

Canadian Journal of Physiology and Pharmacology
Eman SaidRania R Abdelaziz

Abstract

The world-wide increase in cancer incidence imposes a corresponding significant increase in the use of chemotherapeutic agents. Nephrotoxicity is a side effect frequently encountered with cyclophosphamide (CP), which is also well-known to cause acute and chronic lung toxicities. The current study focuses on the evaluation of the potential protective efficacy of tranilast against acute and subacute CP-induced lung and kidney injuries in male Swiss Albino mice. Intraperitoneal CP significantly impaired oxidant/anti-oxidant balance and increased inflammatory cell count in bronchoalveolar lavage fluid, serum creatinine, blood urea nitrogen (BUN), tumor necrosis factor-α (TNF-α) and lactate dehydrogenase (LDH) levels, with significant impairment of lung and kidney architectures. Tranilast taken orally for 8 and 14 days significantly enhanced mice anti-oxidant defense mechanisms; it increased lung and kidney SOD activity, GSH content and reduced lipid peroxidation. Tranilast significantly reduced serum creatinine and BUN. Furthermore, it decreased accumulation of inflammatory cells in the lungs. Serum TNF-α, LDH, total lung and kidney protein contents significantly declined as well. Histopathological examination revealed concomitant ...Continue Reading

References

Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Nov 15, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·K Satoh
Jun 1, 1987·Journal of Pharmacobio-dynamics·Y MiyachiY Niwa
Jul 1, 1989·Analytical Biochemistry·R E BrownK J Hyland
Jan 31, 1972·Biochemical and Biophysical Research Communications·M NishikimiK Yagi
Oct 1, 1994·Journal of Biochemistry·H YamadaS R Pinnell
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·J H McDonough, T M Shih
May 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·S KoyamaT Izumi
Jul 5, 2001·Bone Marrow Transplantation·R BhagatR J Folz
Jul 17, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·R DhamiE H Schuchman
Feb 9, 2005·Current Opinion in Pulmonary Medicine·Binaya RimalWilliam N Rom
Aug 16, 2006·Seminars in Respiratory and Critical Care Medicine·Lorraine B Ware
Jan 24, 2007·American Journal of Respiratory Cell and Molecular Biology·Natasha R LockeMimi L Tang
Aug 28, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Darren J KellyRichard E Gilbert
Mar 27, 2009·Anti-cancer Drugs·Rabindranath ChakrabartiGérald J Prud'homme
Feb 11, 2010·Anti-cancer Drugs·Venkateswaran SubramaniamSerge Jothy
Jun 25, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sih Min TanWeier Qi
Jan 27, 2012·Inflammopharmacology·Eman SaidElsayed M Ammar
Oct 23, 2013·Journal of Biomedical Science·Sara Darakhshan, Ali Ghanbari
Apr 23, 2014·PloS One·Tien Van PhanHye-Seon Choi

❮ Previous
Next ❯

Citations

Feb 9, 2017·Canadian Journal of Physiology and Pharmacology·Sibel GunesRuhi Uyar
Sep 9, 2018·Journal of Biochemical and Molecular Toxicology·Mohammed S El-AwadyHany N Baraka
Feb 12, 2020·Journal of Biochemical and Molecular Toxicology·Manar Gamal Helal, Eman Said
Jul 12, 2017·Fundamental & Clinical Pharmacology·Mehdi GoudarziSaeed Mehrzadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.